The purpose of this webpage and subsequent document is to provide information to existing and prospective investors, and potential commercial partners, about the current status of BCAL’s research and development. It is not intended to promote the use or supply of any therapeutic goods.
BCAL has developed and adopted comprehensive systems of control and accountability as the basis for the administration of corporate governance, based on the ASX Corporate Governance Council’s Corporate Governance Principles and Recommendations. The BCAL Diagnostic Board is committed to ensuring the policies and procedures are managed with honesty, integrity, openness and transparency. A strong values based governance structure is key to the foundation and fundamentals of the company. Ensuring it is reflected in all in which we do. The main policies are provided below:
Corporate Governance Statement
Shareholder Communications Policy
Audit and Risk Management Committee
Diversity and Inclusion Policy
Remuneration and Nominations Committee Charter
Anti-bribery and Corruption Policy